In previous studies, we have proven the beneficial roles of DHF pre‐ or post‐treatment in the case of traumatic brain injury by activating the BDNF receptor TrkB, promoting newborn neuron survival, and enhancing newborn neuron dendritic development (Chen et al., 2015; Zhao et al., 2015). This evidence concerns the gene NTRK2 and injury.